Advanced search
Start date

Maurício dos Santos Pereira


Universidade de São Paulo (USP). Faculdade de Odontologia de Ribeirão Preto (FORP)  (Institutional affiliation for the last research proposal)
Birthplace: Brazil

Post-doctoral fellow at the Institut du cerveau et de la Moelle Épinière (Sorbonne, Paris), in association with University of São Paulo (Dentistry School of RIbeirão Preto). His actual area of research is the characterization of inflammation in L-DOPA induced dyskinesia, focusing on cannabinoid system. He holds a PhD from the Physiology Department of Ribeirão Preto Medical School and a Master's from the Neuroscience Program of the Fluminense Federal University. Undergraduate in Biomedicine, with emphasis in Scientific Research in the area of Physiology and Pharmacology. He worked with dopaminergic activity in experimental models for Attention Deficit / Hyperactivity Disorder (ADHD), having knowledge of techniques such as neurotransmitter uptake and release, cAMP assay, Western blotting and Binding of receptors, as well as behavioral tests such as elevated plus maze and open field. (Source: Lattes Curriculum)

Scholarships in Brazil
Scholarships abroad
FAPESP support in numbers * Updated April 10, 2021
Total / Available in English
Most frequent collaborators in research granted by FAPESP
Contact researcher

Use this Research Supported by FAPESP (BV/FAPESP) channel only to send messages referring to FAPESP-funded scientific projects.





Keywords used by the researcher
Scientific publications resulting from Research Grants and Scholarships under the grantee's responsibility (4)

(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)

Data from Web of Science

GONZALEZ-LIZARRAGA, FLORENCIA L.; PLOPER, DIEGO; AVILA, CESAR L.; SOCIAS, SERGIO B.; DOS-SANTOS-PEREIRA, MAURICIO; MACHIN, BELEN; DEL-BEL, ELAINE; MICHEL, PATRICK PIERRE; PIETRASANTA, I, LIA; RAISMAN-VOZARI, RITA; et al. CMT-3 targets different alpha-synuclein aggregates mitigating their toxic and inflammogenic effects. SCIENTIFIC REPORTS, v. 10, n. 1, . Web of Science Citations: 0. (17/24304-0, 18/03482-0, 14/25029-4, 17/14207-7)

DOS SANTOS PEREIRA, MAURICIO; ABREU, GABRIEL HENRIQUE DIAS; ROCCA, JEREMY; HAMADAT, SABAH; RAISMAN-VOZARI, RITA; MICHEL, PATRICK PIERRE; DEL BEL, ELAINE. Contributive Role of TNF-alpha to L-DOPA-Induced Dyskinesia in a Unilateral 6-OHDA Lesion Model of Parkinson's Disease. FRONTIERS IN PHARMACOLOGY, v. 11, . Web of Science Citations: 0. (14/25029-4, 18/03482-0, 17/24304-0, 17/14207-7)

DOS-SANTOS-PEREIRA, MAURICIO; GUIMARAES, FRANSCISCO S.; DEL-BEL, ELAINE; RAISMAN-VOZARI, RITA; MICHEL, PATRICK P.. Cannabidiol prevents LPS-induced microglial inflammation by inhibiting ROS/NF-kappa B-dependent signaling and glucose consumption. Glia, v. 68, n. 3, p. 561-573, . Web of Science Citations: 0. (18/03482-0, 14/25029-4, 17/14207-7)

FERREIRA JUNIOR, NILSON CARLOS; DOS-SANTOS-PEREIRA, MAURICIO; GUIMARAES, FRANCISCO SILVEIRA; DEL BEL, ELAINE. Cannabidiol and Cannabinoid Compounds as Potential Strategies for Treating Parkinson's Disease and l-DOPA-Induced Dyskinesia. NEUROTOXICITY RESEARCH, . Web of Science Citations: 0. (12/17626-7, 14/25029-4, 17/14207-7)

Please report errors in researcher information by writing to:

Report errors in this page

Error details: